Home>
US Stocks>
Medpace Holdings, Inc.

Medpace Holdings, Inc. share price today

(MEDP)

Medpace Holdings, Inc. share price is $350.53 & ₹29,686.39 as on 7 Dec 2024, 2.30 'hrs' IST

$350.53

▲

8.23

(2.4%)

Market is closed - opens 8 PM, 09 Dec 2024

View live Medpace Holdings, Inc. share price in Dollar and Rupees. Guide to invest in Medpace Holdings, Inc. from India. Also see the sentimental analysis on Indian investors investing in Medpace Holdings, Inc.. Get details on the Indian mutual funds that are investing in Medpace Holdings, Inc.. Get Analyst recommendations and forecasts along with all the Medpace Holdings, Inc.'s financials.

Medpace Holdings, Inc. share price movements

$343.33
$352.43
$350.53
2.06%
Downside
Day's Volatility :2.58%
Upside
0.54%
$277.72
$459.77
$350.53
20.77%
Downside
52 Weeks Volatility :39.6%
Upside
23.76%

Medpace Holdings, Inc. Returns

Period	Medpace Holdings, Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	0.86%	-5.7%	0.0%
6 Months	-15.62%	-0.9%	0.0%
1 Year	21.44%	9.9%	0.0%
3 Years	67.25%	8.4%	-22.1%

Medpace Holdings, Inc. Key Statistics

in dollars & INR

Previous Close	$342.3
Open	$344.09
Today's High	$352.425
Today's Low	$343.325
Market Capitalization	$10.8B
Today's Volume	$262.4K
52 Week High	$459.77
52 Week Low	$277.72
Revenue TTM	$2.1B
EBITDA	$437.5M
Earnings Per Share (EPS)	$11.43
PE Ratio	30.3
Profit Margin	17.66%
Quarterly Earnings Growth YOY	0.36%
Return On Equity TTM	54.08%

How to invest in Medpace Holdings, Inc. from India?

It is very easy for Indian residents to invest directly in Medpace Holdings, Inc. from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Medpace Holdings, Inc. stock in both rupees (INR) and dollars (USD). Search for Medpace Holdings, Inc. or MEDP on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Medpace Holdings, Inc. or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Medpace Holdings, Inc. shares which would translate to 0.002 fractional shares of Medpace Holdings, Inc. as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Medpace Holdings, Inc.

-2%

Period: Sep 9, 2024 to Dec 8, 2024. Change in 30 Days versus previous period

Search volume for Medpace Holdings, Inc. on INDmoney from India has reduced in the last 30 days as on Dec 9, 2024. -2% less investors are searching Medpace Holdings, Inc. in the last 30 days versus the previous period.

Global Institutional Holdings in Medpace Holdings, Inc.

BlackRock Inc
8.30%
Vanguard Group Inc
8.19%
Wasatch Advisors LP
2.92%
State Street Corp
2.42%
Geode Capital Management, LLC
2.02%
Amvescap Plc.
1.82%

Analyst Recommendation on Medpace Holdings, Inc.

Buy

83%Buy

16%Hold

0%Sell

Based on 12 Wall street analysts offering stock ratings for Medpace Holdings, Inc.(by analysts ranked 0 to 5 stars)

Based on 12 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Medpace Holdings, Inc.

What analysts predicted

Downside of 0.74%

Current:

$350.53

Target:

$347.92

Insights on Medpace Holdings, Inc.

Increasing Revenue
Revenue is up for the last 18 quarters, 204.99M → 533.31M (in $), with an average increase of 5.4% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, 88.35M → 96.42M (in $), with an average increase of 8.4% per quarter

Medpace Holdings, Inc. Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$704.6M	↑ 61.55%
Net Income	$73.2M	↑ 87.07%
Net Profit Margin	10.39%	↑ 1.42%

	FY19	Y/Y Change
Revenue	$861.0M	↑ 22.19%
Net Income	$100.4M	↑ 37.25%
Net Profit Margin	11.67%	↑ 1.28%

	FY20	Y/Y Change
Revenue	$925.9M	↑ 7.54%
Net Income	$144.9M	↑ 44.29%
Net Profit Margin	15.65%	↑ 3.98%

	FY21	Y/Y Change
Revenue	$1.1B	↑ 23.38%
Net Income	$181.4M	↑ 25.16%
Net Profit Margin	15.88%	↑ 0.23%

	FY22	Y/Y Change
Revenue	$1.5B	↑ 27.8%
Net Income	$245.2M	↑ 35.18%
Net Profit Margin	16.8%	↑ 0.92%

	FY23	Y/Y Change
Revenue	$1.9B	↑ 29.17%
Net Income	$282.8M	↑ 15.33%
Net Profit Margin	15.0%	↓ 1.8%

	Q2 FY23	Q/Q Change
Revenue	$460.9M	↑ 6.17%
Net Income	$61.1M	↓ 16.22%
Net Profit Margin	13.25%	↓ 3.54%

	Q3 FY23	Q/Q Change
Revenue	$492.5M	↑ 6.86%
Net Income	$70.5M	↑ 15.45%
Net Profit Margin	14.32%	↑ 1.07%

	Q4 FY23	Q/Q Change
Revenue	$498.4M	↑ 1.2%
Net Income	$78.2M	↑ 10.98%
Net Profit Margin	15.7%	↑ 1.38%

	Q1 FY24	Q/Q Change
Revenue	$511.0M	↑ 2.54%
Net Income	$102.5M	↑ 31.06%
Net Profit Margin	20.07%	↑ 4.37%

	Q2 FY24	Q/Q Change
Revenue	$528.1M	↑ 3.34%
Net Income	$88.4M	↓ 13.84%
Net Profit Margin	16.73%	↓ 3.34%

	Q3 FY24	Q/Q Change
Revenue	$533.3M	↑ 0.99%
Net Income	$96.4M	↑ 9.14%
Net Profit Margin	18.08%	↑ 1.35%

	FY18	Y/Y Change
Total Assets	$967.9M	↑ 1.81%
Total Liabilities	$378.2M	↓ 15.42%

	FY19	Y/Y Change
Total Assets	$1.1B	↑ 18.09%
Total Liabilities	$416.8M	↑ 10.19%

	FY20	Y/Y Change
Total Assets	$1.4B	↑ 21.66%
Total Liabilities	$584.9M	↑ 40.33%

	FY21	Y/Y Change
Total Assets	$1.7B	↑ 19.36%
Total Liabilities	$707.0M	↑ 20.88%

	FY22	Y/Y Change
Total Assets	$1.4B	↓ 18.52%
Total Liabilities	$966.1M	↑ 36.65%

	FY23	Y/Y Change
Total Assets	$1.7B	↑ 22.5%
Total Liabilities	$1.1B	↑ 13.64%

	Q2 FY23	Q/Q Change
Total Assets	$1.4B	↑ 0.8%
Total Liabilities	$1.0B	↓ 3.11%

	Q3 FY23	Q/Q Change
Total Assets	$1.5B	↑ 5.67%
Total Liabilities	$1.0B	↓ 0.01%

	Q4 FY23	Q/Q Change
Total Assets	$1.7B	↑ 11.44%
Total Liabilities	$1.1B	↑ 8.08%

	Q1 FY24	Q/Q Change
Total Assets	$1.8B	↑ 8.39%
Total Liabilities	$1.1B	↑ 2.4%

	Q2 FY24	Q/Q Change
Total Assets	$1.9B	↑ 6.92%
Total Liabilities	$1.2B	↑ 2.86%

	Q3 FY24	Q/Q Change
Total Assets	$2.1B	↑ 8.54%
Total Liabilities	$1.2B	↑ 3.99%

	FY18	Y/Y Change
Operating Cash Flow	$156.6M	↑ 60.79%
Investing Cash Flow	$-17.0M	↑ 38.7%
Financing Cash Flow	$-141.6M	↑ 44.72%

	FY19	Y/Y Change
Operating Cash Flow	$201.9M	↑ 28.92%
Investing Cash Flow	$-19.1M	↑ 12.79%
Financing Cash Flow	$-73.9M	↓ 47.79%

	FY20	Y/Y Change
Operating Cash Flow	$258.7M	↑ 28.14%
Investing Cash Flow	$-31.2M	↑ 63.05%
Financing Cash Flow	$-82.3M	↑ 11.32%

	FY21	Y/Y Change
Operating Cash Flow	$263.3M	↑ 1.8%
Investing Cash Flow	$-31.4M	↑ 0.48%
Financing Cash Flow	$-44.5M	↓ 45.97%

	FY22	Y/Y Change
Operating Cash Flow	$388.1M	↑ 47.36%
Investing Cash Flow	$-38.7M	↑ 23.52%
Financing Cash Flow	$-775.8M	↑ 1645.16%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$82.5M	↑ 3.05%
Investing Cash Flow	$-8.5M	↓ 10.9%
Financing Cash Flow	$-82.2M	↑ 56.05%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$114.4M	↑ 38.62%
Investing Cash Flow	$-8.7M	↑ 2.3%
Financing Cash Flow	$-49.3M	↓ 40.07%

Medpace Holdings, Inc. Technicals Summary

Sell

Neutral

Buy

Medpace Holdings, Inc. is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Medpace Holdings, Inc. Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Medpace Holdings, Inc.	-5.85%	-15.62%	21.44%	67.25%	331.76%
Medpace Holdings, Inc.	-1.34%	-15.89%	-20.26%	-29.68%	70.69%
Medpace Holdings, Inc.	0.87%	3.64%	6.9%	-11.77%	65.27%
Medpace Holdings, Inc.	-5.6%	-10.43%	5.23%	-18.93%	63.75%
Medpace Holdings, Inc.	-7.14%	-13.9%	2.95%	-28.23%	52.25%
Medpace Holdings, Inc.	-8.8%	-7.37%	-7.57%	-26.04%	38.99%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Medpace Holdings, Inc.	30.3	30.3	1.61	12.29	0.54	0.14	NA	28.42
Medpace Holdings, Inc.	41.3	41.3	4.5	10.73	0.59	0.23	NA	19.72
Medpace Holdings, Inc.	31.62	31.62	2.38	5.24	0.25	0.08	0.01	20.53
Medpace Holdings, Inc.	32.68	32.68	1.99	21.69	0.13	0.05	0.0	128.08
Medpace Holdings, Inc.	42.91	42.91	3.04	7.5	0.08	0.04	0.0	71.03
Medpace Holdings, Inc.	26.66	26.66	1.05	11.12	0.22	0.05	NA	38.37

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Medpace Holdings, Inc.	Buy	$10.8B	331.76%	30.3	17.66%
Medpace Holdings, Inc.	Buy	$35.0B	70.69%	41.3	22.53%
Medpace Holdings, Inc.	Buy	$40.0B	65.27%	31.62	21.75%
Medpace Holdings, Inc.	Buy	$199.2B	63.75%	32.68	14.48%
Medpace Holdings, Inc.	Buy	$164.6B	52.25%	42.91	16.39%
Medpace Holdings, Inc.	Buy	$36.9B	38.99%	26.66	9.17%

About Medpace Holdings, Inc.

a therapeutically focused leader in research-based drug development, medpace builds strong strategic partnerships with select sponsors to advance the most efficient and cost-effective path to drug approval. as a full service, global clinical research organization (cro), medpace sees itself as a steward of your drug, leveraging its extensive medical and regulatory expertise to deliver additional input, strategy, and efficiencies to each and every phase of the clinical trial. from custom solutions addressing the needs of small and midsize biotechnology companies to full-service offerings for global pharmaceutical companies, medpace has the breadth, depth, and flexibility to deliver a superior result, specific to your needs, on six continents.

Organization	Medpace Holdings, Inc.
Employees	5900
CEO	Dr. August James Troendle M.D.
Industry	Commercial Services

Management People of Medpace Holdings, Inc.

Name	Title
Dr. August James Troendle M.D.	Chairman & CEO
Mr. Jesse J. Geiger BBA, CPA	President
Mr. Kevin M. Brady	CFO & Treasurer
Ms. Susan E. Burwig BSN, MA	Executive Vice President of Operations
Mr. Stephen P. Ewald J.D.	Chief Compliance Officer, General Counsel & Corporate Secretary
Brandon Ebken	Chief Information Officer
Ms. Lauren Morris	Associate Director of Investors Relations
Mr. Todd Meyers	Vice President of Business Development & Marketing
John T. Wynne MBA	Senior Vice President of Commercial Operations & Clinical Pharmacology Unit
Mr. Reinilde Heyrman M.D.	Chief Medical Officer of Medical Department

Important FAQs about investing in Medpace Holdings, Inc. from India :

What is Medpace Holdings, Inc. share price today?

Medpace Holdings, Inc. (MEDP) share price today is $350.53.

Can Indians buy Medpace Holdings, Inc. shares?

Yes, Indians can invest in the Medpace Holdings, Inc. (MEDP) from India.

With INDmoney, you can buy Medpace Holdings, Inc. at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Medpace Holdings, Inc. at zero transaction cost.

How can I buy Medpace Holdings, Inc. shares from India?

It is very easy to buy Medpace Holdings, Inc. from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Medpace Holdings, Inc. be purchased?

Yes, you can buy fractional shares of Medpace Holdings, Inc. with INDmoney app.

What are the documents required to start investing in Medpace Holdings, Inc. stocks?

To start investing in Medpace Holdings, Inc., You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.